Defunct Company
Total Trials
2
As Lead Sponsor
As Collaborator
0
Total Enrollment
168
NCT02058680
Phase 1A/1B Study of PSA/IL-2/GM-CSF Vaccine for Recurrent Prostate Cancer in Hormone Naive and Hormone Independent Patients
Phase: Phase 1
Role: Lead Sponsor
Start: Apr 30, 2012
Completion: Dec 31, 2018
NCT03579654
Study of Proscavax Vaccine in Patients With Localized Prostate Cancer vs Active Surveillance
Phase: Phase 2
Start: Feb 28, 2019
Completion: Jun 30, 2022